Andrew C Lake Selected Research

Cytokines

1/2020

The Fully human anti-CD47 antibody SRF231 exerts dual-mechanism antitumor activity via engagement of the activating receptor CD32a.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrew C Lake Research Topics

Disease

2	Neoplasms (Cancer) 01/2020 - 03/2004
1	Ischemia 12/2006
1	Carcinogenesis 03/2004
1	Leiomyoma (Uterine Fibroids) 03/2004
1	Vascular Diseases (Vascular Disease) 11/2003
1	Wilms Tumor (Wilm's Tumor) 01/2003

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 01/2020 - 03/2004
2	Heparin (Liquaemin)FDA LinkGeneric 12/2006 - 03/2004
1	CytokinesIBA 01/2020
1	Chemokine CCL3IBA 01/2020
1	Chemotactic FactorsIBA 01/2020
1	fucoidanIBA 12/2006
1	Biological ProductsIBA 12/2006
1	Polysaccharides (Glycans)IBA 12/2006
1	Messenger RNA (mRNA)IBA 03/2004
1	Cysteine (L-Cysteine)FDA Link 01/2003
1	Connective Tissue Growth FactorIBA 01/2003

Therapy/Procedure

1	Therapeutics 11/2003